Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 3, 2000, Pages 407-409

  Bermúdez, Eduardo Pinar ^a   García Alberola, Arcadio ^a,b   Sánchez, Juan Martínez ^a   Muñoz, Juan José Sánchez ^a   Chávarri, Mariano Valdés ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

Ajmaline; Brugada syndrome; Monomorphic ventricular tachycardia

Indexed keywords

AJMALINE;

ADOLESCENT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; ELECTROCARDIOGRAM; HEART REPOLARIZATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; ST SEGMENT ELEVATION; SUDDEN DEATH;

EID: 0034018879     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb06771.x     Document Type: Article

References (14)

1. 1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992; 20:1391-1396.
2. 2. Gussak I, Antzelevitch C, Bjerregaard P, et al. The Brugada syndrome: Clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999; 33:5-15.
3. 3. Brugada J, Brugada P. Further characterization of the syndrome of right bundle branch block, ST segment elevation and sudden cardiac death. J Cardiovasc Electrophysiol 1997; 8:325-331.
4. 4. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27:1061-1070.
5. 5. Goethals P, Debruyne P, Saffarian M. Drug-induced Brugada syndrome. Acta Cardiol 1998; 53:157-160.
6. 6. Shimada M, Miyazaki T, Miyoshi S, et al. Sustained monomorphic ventricular tachycardia in a patient with Brugada syndrome. Jpn Circ J 1996; 60:364-370.
7. 7. Krishnan SC, Josephson ME. ST segment elevation induced by class IC antiarrhythmic agents: Underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia. J Cardiovasc Electrophysiol 1998; 11:1167-1172.
8. 8. Fujiki A, Usui M, Nagasawa H, et al. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: Insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10:214-218.
9. 9. Roden DM, Wilde A. Drug-induced J point elevation: A marker for genetic risk of sudden death or ECG curiosity? J Cardiovasc Electrophysiol 1999; 10:219-223.
10. 10. Matsuo K, Shimizu W, Kurita T, et al. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998; 9:508-512.
11. 11. Chinushi M, Aizawa Y, Ogawa Y, et al. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. J Electrocardiol 1997; 30:133-136.
12. 12. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392:293-296.
13. 13. Krishnan SC, Antzelevitch C. Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res 1991; 69:277-291.
14. 14. Krishnan SC, Antzelevitch C. Flecainide-induced arrhythmia in canine ventricular epicardium: Phase 2 reentry? Circulation 1993; 87:562-572.